A real-world study of Afatinib plus ramucirumab in treatment-naïve, EGFR-mutated, non–small cell lung cancer

被引：0
|
作者：
Chun-Yao Huang
Hui-Li Huang
Chou-Chin Lan
Yi-Chih Huang
Yao-Kuang Wu
机构：
[1] Taipei Tzu Chi Hospital,Division of Pulmonary Medicine
[2] Buddhist Tzu Chi Medical Foundation,undefined
来源：
BMC Cancer | / 23卷
关键词：
Afatinib; Ramucirumab; Non–small cell lung cancer; mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A real-world study of Afatinib plus ramucirumab in treatment-naive, EGFR-mutated, non-small cell lung cancer
    Huang, Chun-Yao
    Huang, Hui-Li
    Lan, Chou-Chin
    Huang, Yi-Chih
    Wu, Yao-Kuang
    [J]. BMC CANCER, 2023, 23 (01)
  • [2] Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational Study
    Cheng, Wen-Chien
    Shen, Yi-Cheng
    Chen, Chieh-Lung
    Liao, Wei-Chih
    Chen, Chia-Hung
    Chen, Hung-Jen
    Tu, Chih-Yen
    Hsia, Te-Chun
    [J]. CANCERS, 2023, 15 (03)
  • [3] Single-Center Real-World Study of First Line Afatinib Treatment in Advanced EGFR-mutated Non-small Cell Lung Cancer in Vietnam
    Pham, C. T. M.
    Hoang, T. T. A.
    Truong, P. T.
    Bui, P. T. T.
    Nguyen, T. T.
    Vo, T. N.
    Tran, D. T.
    Nguyen, D. T.
    Tran, T. X.
    Le, H. H.
    Dong, H. Q.
    Nguyen, K. T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S662 - S663
  • [4] Furmonertinib treatment in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, H.
    Wang, L.
    Wu, Y.
    Wu, Y.
    Ma, S.
    Sen, Y.
    Zhen, H.
    Mo, Y.
    Zhang, C.
    Wang, Q.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1697 - S1697
  • [5] Selectivity profile of afatinib for EGFR-mutated non-small-cell lung cancer
    Wang, Debby D.
    Lee, Victor H. F.
    Zhu, Guangyu
    Zou, Bin
    Ma, Lichun
    Yan, Hong
    [J]. MOLECULAR BIOSYSTEMS, 2016, 12 (05) : 1552 - 1563
  • [6] Efficacy and prognostic factors of first-line afatinib treatment for the EGFR-mutated non-small cell lung cancer in the real world
    Chiu, Tzu Hsuan
    Huang, Chi-Hsien
    Kuo, Chih-Hsi Scott
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [7] Ischemic stroke in a patient with EGFR-mutated non-small-cell lung cancer after treatment with ramucirumab
    Chen, Guo-Yu
    Cheng, Wen-Chien
    Tu, Chih-Yen
    [J]. THORACIC CANCER, 2022, 13 (23) : 3412 - 3414
  • [8] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in EGFR-mutated non-small cell lung cancer: A real-world study
    Hu, Chunhong
    Wu, Sixuan
    Deng, Renfang
    Wu, Yuanqiang
    Pan, Yue
    Shu, Long
    Wu, Fang
    [J]. CANCER MEDICINE, 2023, 12 (01): : 266 - 273
  • [9] Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer
    Zhang, Xiaojuan
    Zhang, Mina
    Du, Xinyang
    Zhang, Guowei
    Niu, Yuanyuan
    Wei, Chunhua
    Guo, Lanwei
    Shi, Chao
    Liu, Hangfan
    Wang, Huijuan
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study
    Cliff Molife
    Katherine B. Winfree
    Hollie Bailey
    Yulia D’yachkova
    Cameron Forshaw
    Sangmi Kim
    Kaisa-Leena Taipale
    Tarun Puri
    [J]. Advances in Therapy, 2023, 40 : 3135 - 3168
12345